Portfolio company
Fable Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops protein-engineered biologics using machine learning to treat patients with obesity and metabolic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ousia Pharma
This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.
Tanai Therapeutics
This company develops oral small molecule therapeutics targeting energy expenditure pathways to treat obesity and cardiometabolic diseases for patients.
Moonwalk Biosciences
The company develops adipose-targeted RNA therapies to treat obesity and cardiometabolic diseases for patients requiring weight loss and lean mass preservation.
UbiquiTx
This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.
Kailera
This biopharmaceutical company develops injectable and oral therapies for the treatment of obesity and related metabolic conditions.
Alveus Therapeutics
This clinical-stage biotechnology company develops next-generation therapies for obesity and metabolic diseases to provide sustained weight loss for patients.
Metsera
The company develops injectable and oral medicines for patients with obesity and metabolic diseases.
Hawkhill Therapeutics
This company develops oral small molecule therapies for obesity and metabolic health to preserve muscle mass for the biotechnology and pharmaceutical sectors.